Induction chemotherapy with albumin-bound paclitaxel plus lobaplatin followed by concurrent radiochemotherapy for locally advanced esophageal cancer

BACKGROUND: Albumin-bound paclitaxel (ABP) has been used as second- and higher-line treatments for advanced esophageal cancer, and its efficacy and safety have been well demonstrated. Lobaplatin (LBP) is a third-generation platinum antitumor agent; compared with the first two generations of platinum...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Mao-Hui, Liu, Fang, Qu, Bao-Lin, Cai, Bo-Ning, Yu, Wei, Dai, Xiang-Kun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2021
Materias:
Clinical Trials Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603460/
https://www.ncbi.nlm.nih.gov/pubmed/34853650
http://dx.doi.org/10.4251/wjgo.v13.i11.1781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8603460/
https://www.ncbi.nlm.nih.gov/pubmed/34853650
http://dx.doi.org/10.4251/wjgo.v13.i11.1781

Ejemplares similares